CLLS ▼ -1.0% - Cellectis S.A.
$CLLS - Cellectis Presents Preclinical Data Highlighting Efficient APOC3 Editing and Marked Triglyceride Reduction with .HEAL-101 at ESGCT 2026
27-OCT-2026 03:15 AM ET
Share this post
More filings for $CLLS
View full $CLLS filing history →💬 Comments
Loading comments…
Leave a comment
